MBCL-33. HEPATOTOXICITY DURING INDUCTION CHEMOTHERAPY, WITH OR WITHOUT HIGH-DOSE METHOTREXATE (HD-MTX), ON THE HEAD START II TRIAL FOR PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

INTRODUCTION: The incidence of hepatotoxicity has never been reported for intensive induction chemotherapy regimens for young children with primary malignant CNS tumors. We report our comprehensive review of available data on patients enrolled on the Head Start II trial 1997-2003. METHODS: Retrospec...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Abu Arja, Mohammad H, Mehyar, Lubna S, Osorio, Diana S, Coven, Scott, Gardner, Sharon, Finlay, Jonathan L
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012657/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.429
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi